title: [Effects of Tongxinluo on cell viability and tissue factor in AngII induced vascular endothelial cells].
abstract: OBJECTIVE
  To determine the effects of Tongxinluo on cell viability and tissue factor (TF) in AngII induced vascular endothelial cells and to investigate its mechanism.
  
  
  METHODS
  AngII(10(-6)mol/L) was added to human vascular endothelial cells (HUVECs) culture media alone or with various concentration of Tongxinluo drug containing plasma (5%,10%, and 20%) added 30 minutes before AngII. Cell viability was evaluated after 24-hour incubation with AngII in a dose manner. TF, AngII type 1 receptor (AT(1)) mRNA, NO synthase (NOS) and NO were observed after 24-hour incubation with AngII. In addition, NOS inhibitor nomega-nitro-larginine (L-NAME) was added 30 minutes before Tongxinluo and AngII. Cell viability, TF, AT(1)mRNA, the level of NOS and NO were evaluated after 24-hour incubation with Tongxinluo and AngII.
  
  
  RESULTS
  Tongxinluo significantly improved AngII induced endothelial cell viability and the effect was the most obvious at 10%. Tongxinluo (10%) decreased the TF and AT(1) mRNA while increased the NOS and NO levels. L-NAME obviously inhibited the effects of Tongxinluo on cell viability, TF, AT(1) mRNA, and NOS and NO levels.
  
  
  CONCLUSIONS
  Up-regulating NOS-NO signaling may be the mechanism of Tongxinluo on cell viability and TF in AngII induced vacular endothelial cells.
authors.affiliation: Department of Cardiology, Xiangya Hospital, Central South University, Changsha 410008, China.
authors.forename: Qi-lin
authors.initials: QL
authors.lastname: Ma
authors.forename: Ming
authors.initials: M
authors.lastname: Sun
authors.forename: Tian-lun
authors.initials: TL
authors.lastname: Yang
authors.forename: Yuan-jian
authors.initials: YJ
authors.lastname: Li
authors.forename: Can-e
authors.initials: CE
authors.lastname: Tang
authors.forename: Zhen-yu
authors.initials: ZY
authors.lastname: Peng
authors.forename: Shi-lin
authors.initials: SL
authors.lastname: He
authors.forename: Fang-ping
authors.initials: FP
authors.lastname: Chen
mesh_terms: D000804:Angiotensin II / Q000494:pharmacology*; D002460:Cell Line; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D004365:Drugs, Chinese Herbal / Q000494:pharmacology*; D004730:Endothelium, Vascular / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D004791:Enzyme Inhibitors; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D019331:NG-Nitroarginine Methyl Ester / Q000494:pharmacology; D052248:Nitric Oxide Synthase Type I / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000235:genetics; D012333:RNA, Messenger / Q000096:biosynthesis / Q000235:genetics; D044140:Receptor, Angiotensin, Type 1 / Q000096:biosynthesis / Q000235:genetics; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013925:Thromboplastin / Q000096:biosynthesis* / Q000235:genetics
chemical_list: D004365:Drugs, Chinese Herbal; D004791:Enzyme Inhibitors; D012333:RNA, Messenger; D044140:Receptor, Angiotensin, Type 1; C513941:tongxinluo; D000804:Angiotensin II; D013925:Thromboplastin; D052248:Nitric Oxide Synthase Type I; D019331:NG-Nitroarginine Methyl Ester